Townsend John

Townsend John is listed in filings as CFO at Unicycive Therapeutics, Inc.. This profile follows SEC Form 4 activity through May 20, 2026, including 3 public disclosures. Recent filings connect the profile to Unicycive Therapeutics, Inc. (UNCY). The current snapshot covers public activity from Aug 14, 2024 to May 20, 2026. Reported amounts are shown as $47.1K to $13.7K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.